Schonfeld Strategic Advisors LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$96,081
-80.6%
22,241
-55.5%
0.00%
-75.0%
Q3 2022$494,000
+187.2%
49,991
+399.9%
0.00%
+100.0%
Q3 2021$172,000
-26.8%
10,000
-30.0%
0.00%
-66.7%
Q4 2019$235,000
-67.3%
14,284
-66.9%
0.01%
-95.1%
Q3 2016$719,00043,1690.12%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,658,759$121,733,0008.95%
Palo Alto Investors LP 4,155,670$108,588,0005.78%
Stonepine Capital Management, LLC 220,848$5,771,0005.07%
Birchview Capital, LP 80,000$2,090,0001.98%
EAM Global Investors LLC 75,310$1,968,0001.08%
Atika Capital Management LLC 130,000$3,397,0001.00%
EAM Investors, LLC 110,806$2,895,0000.79%
UNIVERSITY OF NOTRE DAME DU LAC 97,521$2,548,0000.62%
ALGERT GLOBAL LLC 76,204$1,991,0000.56%
361 CAPITAL LLC 85,885$2,244,0000.46%
View complete list of VANDA PHARMACEUTICALS INC shareholders